Heart Failure With Reduced Ejection Fraction (HFrEF)

39 clinical trials · Condition

Record	Firm	Date
Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) (NCT05328752)	Novartis Pharmaceuticals	2022-05-17
Effect of Carvedilol Rapid Up-Titration in Patients With Heart Failure With Reduced Ejection Fraction (NCT05179070)	Universitas Sebelas Maret	2021-09-10
Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study (NCT04331769)	Ancora Heart, Inc.	2020-12-21
Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial (NCT04304560)	Damanhour University	2020-03-01
Developing Oral LT3 Therapy for Heart Failure - HFrEF (NCT04112316)	University of Pennsylvania	2020-02-11
Mid-Q Response Study (NCT04180696)	Medtronic Cardiac Rhythm and Heart Failure	2020-01-23
DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction (NCT03877237)	AstraZeneca	2019-04-09
VisONE Heart Failure Study: Pilot (NCT03484780)	VisCardia Inc.	2018-07-25
Translational and Clinical Aspects of Metabolic, Anabolic and Endothelial Dysfunction in Heart Failure (NCT05277415)	Lars Lund	2013-02-17
Predicting Heart Failure Outcomes With Biomarkers and Imaging (NCT07332520)	Xinjiang Medical University	2012-01-01

Every clearance here is in the API, with alerts when new ones post.